alexa Scholarly Open Access Journals In Blood Transfusion|OMICS International|Translational Medicine

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Scholarly Open Access Journals In Blood Transfusion

Scholarly open access journals have emerged as an alternative to traditional subscription journals. Open access scholarly journals are available online to the reader without financial, legal, or technical barriers. Scholarly open access journals are journals which are respected for the extensive research and information they provide about the point. The research often possesses refereed meaning that it is reviewed by other scientists who are knowledgeable about the theme of the article. Scholarly open access journals cite their sources using references or bibliographies. OMICS Group International has 700+ peer-reviewed journals and organizes 3000+ International Scientific Conferences worldwide. Apart from providing a free access to articles to everyone, it also extends support to other scholarly journals in the peer-review process, production, and distribution. All the articles published in OMICS Group journals are peer reviewed and published only on adhering to the norms. Upon acceptance, the articles will be immediately and permanently free for everyone to read and download. OMICS Group International has established agreements with 1000+ Scientific associations by covering some or all of the publication costs for their individual researchers. Total knee arthroplasty usually includes the use of tourniquet in order to induce ischemia during the surgery, resulting in unapparent intraoperative bleeding but substantial postoperative blood loss. Different factors may influence in the surgical bleeding in total knee arthroplasty like coagulation disorders, medication (antiagregants, NSAID, LMWH) and anesthetic technique. Allogeneic blood transfusion is associated with the blood loss during surgery and postoperative drainage, but also with the haemoglobin level before the surgery. Allogeneic blood transfusion is the standard approach to increase haemoglobin (Hb) concentration. But this procedure is not free of risks despite all efforts to avoid them. In addition to well-known risks, such as volume overload, mistransfusion, the transmission of infections, transfusion febrile reactions, transfusion-related acute lung injury, allergic transfusion reactions, or alloimmunization, there is increased morbidity and mortality, and longer hospital stays. These situations justify clinical strategies to minimize exposure to allogeneic blood transfusion. As hyper fibrinolysis is considered the major cause of postoperative bleeding after total knee replacement surgery, anti-fibrinolytic drugs have been proposed. Tranexamic acid (TXA) is a synthetic analog of serin than reversibly inhibits fibrinolysis by blocking lysine union sites in the plasmin and plasminogen activator molecules. It has been extensively used in cardiac surgery, urology, gynaecology, liver transplants and orthopaedic surgery. Only two-dose IV of tranexamic acid can be used in total knee replacement procedures with proven effectiveness and efficiency to decrease postoperative blood loss, decrease risk of allogeneic blood transfusion and decrease length of hospital stay in our patients undergoing total knee arthroplasty.(Raul Cordoba, Blanca Tapia, OlatzAramburu, Maria-Asuncion Mora, Rafael Bielza, Javier Escalera, Jose-Ignacio Lora-Tamayo and Luis Ercoreca, Tranexamic Acid Reduces Blood Transfusion, Postoperative Blood Loss)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014